Hypertension as a risk factor syndrome: therapeutic implications

Area of Science:

• Cardiology
• Hypertension Research
• Vascular Biology

Background:

• Antihypertensive treatment solely focused on blood pressure reduction may be inadequate.
• Clinical trials show inconsistent reductions in major cardiovascular events despite blood pressure control.
• Coronary artery disease reduction is limited, suggesting other factors contribute to atherosclerosis in hypertensive patients.

Purpose of the Study:

• To evaluate the limitations of solely targeting blood pressure in hypertension management.
• To explore the multifaceted cardiovascular changes associated with hypertension beyond elevated blood pressure.
• To advocate for comprehensive therapeutic strategies addressing the full spectrum of hypertension-related abnormalities.

Main Methods:

• Review of clinical trial data on antihypertensive therapy outcomes.
• Analysis of emerging evidence on hypertension's impact on lipid profiles and glucose metabolism.
• Examination of studies investigating early cardiac and arterial structural/functional changes in hypertension.

Main Results:

• Hypertension is linked to increased vulnerability to lipid abnormalities and insulin resistance.
• Insulin resistance in hypertension can promote vascular smooth muscle proliferation and affect lipid profiles.
• Early hypertension involves left ventricular hypertrophy and altered diastolic filling, alongside diminished arterial compliance.

Conclusions:

• Therapeutic strategies for hypertension must extend beyond blood pressure reduction.
• Addressing metabolic and structural cardiovascular changes is crucial for effective hypertension management.
• Angiotensin-converting enzyme inhibitors show promise in reversing hypertension-related cardiovascular abnormalities.